Royalty Pharma plc - Class A — 四半期財務統計 (NASDAQ:RPRX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計配当金

営業活動によるキャッシュフロー 742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B 投資活動によるキャッシュフロー -505.59 M503.92 M-311.98 M-958.31 M-847.8 M -1.61 B 財務活動によるキャッシュフロー -257.96 M-941.3 M-507.81 M562.74 M-299.6 M -1.19 B フリーキャッシュフロー 742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B

ニュース

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

ロイヤルティ・ファーマ、TD Cowenカンファレンスで戦略的成長の見通しを示す

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Stifelがロイヤリティ契約の価値を評価しZymeworks株の目標株価を引き上げ

Citizens reiterates Zymeworks stock rating on strong cash position